| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $4.9B | $4.5B | $4.1B | $3.8B | $0.9B | $1.0B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.1B | $-0.0B | $-0.0B | $0.1B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $0.55 | $0.20 | $-0.10 | $-0.12 | $0.13 | $0.29 | $0.03 | $0.17 |
| EPS (Diluted) | $0.54 | $0.19 | $-0.10 | $-0.12 | $0.13 | $0.29 | $0.03 | $0.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.6B | $26.2B | $24.7B | $24.2B | $24.7B | $23.9B | $24.7B | $22.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $0.9B | $0.5B | $0.1B | $0.1B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | $14.6B | $15.0B | $14.9B | $13.7B | $13.5B | $13.4B | $13.9B | $12.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $12.5B | $10.8B | $9.5B | $10.2B | $10.9B | $10.2B | $10.4B | $10.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.3B | $1.1B | $1.1B | $1.0B | $1.5B | $1.4B | $1.4B |
| Investing Cash Flow | $-2.7B | $-2.4B | $-0.2B | $-0.9B | $-0.7B | $0.2B | $-1.6B | $0.3B |
| Capital Expenditures | — | — | — | — | — | — | $0.2B | $0.1B |
| Financing Cash Flow | $0.9B | $1.4B | $-0.5B | $-0.3B | $-0.6B | $-1.3B | $0.2B | $-1.8B |